Published in Politico
After years of trying, Congress is finally on the verge of passing legislation aimed at lowering prescription drug prices by targeting the intermediaries that help negotiate them.
Jesse Dresser, an attorney and head of law firm Frier Levitt’s pharmacy practice group, said breaking the tie between rebates and compensation in Medicare Part D plans could “radically transform” the way the intermediaries practice.
Jesse said industry players could seek to manufacture their own drugs or integrate with different parts of the drug distribution channel to obtain new revenue sources. Specialty pharmacy revenue has become a larger share of their total revenue over the past several years.
Read more: https://www.politico.com/news/2026/02/02/prescription-drug-costs-pharmacy-benefit-managers-00761503
